The University of Chicago Header Logo

Connection

Jon E. Grant to Gambling

Back to Details
This is a "connection" page, showing publications Jon E. Grant has written about Gambling.
Jon E. Grant
Connection Strength
44.822
Gambling
  1. A familial subtype of gambling disorder. J Behav Addict. 2024 Oct 04; 13(3):761-767.
    View in: PubMed
    Score: 0.768
  2. Suicide Attempts in Gambling Disorder. Prim Care Companion CNS Disord. 2024 Jul 04; 26(4).
    View in: PubMed
    Score: 0.762
  3. Lifetime alcohol use disorder and gambling disorder: clinical profile and treatment response. CNS Spectr. 2024 Aug; 29(4):273-278.
    View in: PubMed
    Score: 0.755
  4. Treatment discontinuation in pharmacological clinical trials for gambling disorder. J Psychiatr Res. 2024 May; 173:210-215.
    View in: PubMed
    Score: 0.748
  5. Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial. Clin Neuropharmacol. 2024 Mar-Apr 01; 47(2):54-58.
    View in: PubMed
    Score: 0.745
  6. Duration of untreated illness in gambling disorder. CNS Spectr. 2024 02; 29(1):54-59.
    View in: PubMed
    Score: 0.721
  7. Does gambling differ in people with a minority sexual orientation? Ann Clin Psychiatry. 2023 02; 35(1):23-30.
    View in: PubMed
    Score: 0.691
  8. Age of gambling onset and resultant gambling behavior during young adulthood in the United States. Am J Addict. 2023 05; 32(3):268-273.
    View in: PubMed
    Score: 0.686
  9. Illegal behaviors as a consequence of gambling disorder. Am J Addict. 2023 01; 32(1):40-46.
    View in: PubMed
    Score: 0.681
  10. Gambling disorder in minority ethnic groups. Addict Behav. 2023 01; 136:107475.
    View in: PubMed
    Score: 0.671
  11. Diverse predictors of treatment response to active medication and placebo in gambling disorder. J Psychiatr Res. 2021 12; 144:96-101.
    View in: PubMed
    Score: 0.630
  12. Screening for adult ADHD using brief rating tools: What can we conclude from a positive screen? Some caveats. Compr Psychiatry. 2021 04; 106:152224.
    View in: PubMed
    Score: 0.601
  13. Family history of substance use disorders: Significance for mental health in young adults who gamble. J Behav Addict. 2020 Jun; 9(2):289-297.
    View in: PubMed
    Score: 0.575
  14. Response of Refractory Gambling Disorder to Intravenous Ketamine. Prim Care Companion CNS Disord. 2020 01 16; 22(1).
    View in: PubMed
    Score: 0.559
  15. Gambling and substance use: Comorbidity and treatment implications. Prog Neuropsychopharmacol Biol Psychiatry. 2020 04 20; 99:109852.
    View in: PubMed
    Score: 0.557
  16. Racial-ethnic differences in impulsivity and compulsivity in recreational gambling. Compr Psychiatry. 2020 02; 97:152153.
    View in: PubMed
    Score: 0.555
  17. Abnormalities of striatal morphology in gambling disorder and at-risk gambling. CNS Spectr. 2019 12; 24(6):609-615.
    View in: PubMed
    Score: 0.555
  18. Longitudinal subtypes of disordered gambling in young adults identified using mixed modeling. Prog Neuropsychopharmacol Biol Psychiatry. 2020 03 08; 97:109799.
    View in: PubMed
    Score: 0.551
  19. Cold pressor pain and gambling disorder: implications for the opioid system. CNS Spectr. 2020 06; 25(3):426-433.
    View in: PubMed
    Score: 0.536
  20. An Analysis of Treatment-Seeking Behavior in Individuals with Gambling Disorder. J Gambl Stud. 2018 Sep; 34(3):999-1012.
    View in: PubMed
    Score: 0.509
  21. Gambling disorder and obsessive-compulsive personality disorder: A frequent but understudied comorbidity. J Behav Addict. 2018 Jun 01; 7(2):366-374.
    View in: PubMed
    Score: 0.500
  22. Problematic internet use as an age-related multifaceted problem: Evidence from a two-site survey. Addict Behav. 2018 06; 81:157-166.
    View in: PubMed
    Score: 0.490
  23. Gambling and its clinical correlates in university students. Int J Psychiatry Clin Pract. 2019 Mar; 23(1):33-39.
    View in: PubMed
    Score: 0.489
  24. How to measure monetary losses in gambling disorder? An evidence-based refinement. Psychiatry Res. 2018 05; 263:220-224.
    View in: PubMed
    Score: 0.483
  25. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1299-e1306.
    View in: PubMed
    Score: 0.480
  26. Problematic internet use in gamblers: impact on clinical and cognitive measures. CNS Spectr. 2017 12; 22(6):495-503.
    View in: PubMed
    Score: 0.476
  27. Calorie Intake and Gambling: Is Fat and Sugar Consumption 'Impulsive'? J Gambl Stud. 2017 Sep; 33(3):783-793.
    View in: PubMed
    Score: 0.475
  28. Caffeine's influence on gambling behavior and other types of impulsivity. Addict Behav. 2018 Jan; 76:156-160.
    View in: PubMed
    Score: 0.473
  29. The placebo effect and its clinical associations in gambling disorder. Ann Clin Psychiatry. 2017 Aug; 29(3):167-172.
    View in: PubMed
    Score: 0.472
  30. Sub-clinical Alcohol Consumption and Gambling Disorder. J Gambl Stud. 2017 Jun; 33(2):473-486.
    View in: PubMed
    Score: 0.466
  31. Gambling disorder: Association between duration of illness, clinical, and neurocognitive variables. J Behav Addict. 2017 Jun 01; 6(2):194-202.
    View in: PubMed
    Score: 0.466
  32. Neurocognitive dysfunction in problem gamblers with co-occurring antisocial personality disorder. Compr Psychiatry. 2017 07; 76:153-159.
    View in: PubMed
    Score: 0.465
  33. Latent class analysis of gambling subtypes and impulsive/compulsive associations: Time to rethink diagnostic boundaries for gambling disorder? Addict Behav. 2017 09; 72:79-85.
    View in: PubMed
    Score: 0.461
  34. Gambling disorder, DSM-5 criteria and symptom severity. Compr Psychiatry. 2017 05; 75:1-5.
    View in: PubMed
    Score: 0.458
  35. Neurocognitive and clinical correlates of gambling behavior based on mode of gambling. Ann Clin Psychiatry. 2016 11; 28(4):232-238.
    View in: PubMed
    Score: 0.448
  36. The intersection of obesity and the longitudinal course of problem gambling. Psychiatry Res. 2016 Dec 30; 246:707-711.
    View in: PubMed
    Score: 0.448
  37. ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity. CNS Spectr. 2017 02; 22(1):22-30.
    View in: PubMed
    Score: 0.445
  38. Cognitive flexibility correlates with gambling severity in young adults. J Psychiatr Res. 2016 10; 81:9-15.
    View in: PubMed
    Score: 0.436
  39. Anxiety, Gambling Activity, and Neurocognition: A Dimensional Approach to a Non-Treatment-Seeking Sample. J Behav Addict. 2016 Jun; 5(2):261-70.
    View in: PubMed
    Score: 0.435
  40. Racial-ethnic related clinical and neurocognitive differences in adults with gambling disorder. Psychiatry Res. 2016 Aug 30; 242:82-87.
    View in: PubMed
    Score: 0.435
  41. Expanding the definition of addiction: DSM-5 vs. ICD-11. CNS Spectr. 2016 Aug; 21(4):300-3.
    View in: PubMed
    Score: 0.433
  42. Impulsivity and gambling: A complex clinical association across three measures. Am J Addict. 2016 Mar; 25(2):138-44.
    View in: PubMed
    Score: 0.426
  43. White matter tract integrity in treatment-resistant gambling disorder. Br J Psychiatry. 2016 06; 208(6):579-84.
    View in: PubMed
    Score: 0.425
  44. Clinical and cognitive correlates of young adult at-risk gamblers with and without depression. Ann Clin Psychiatry. 2015 Nov; 27(4):261-6.
    View in: PubMed
    Score: 0.418
  45. Neural and psychological underpinnings of gambling disorder: A review. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 04; 65:188-93.
    View in: PubMed
    Score: 0.417
  46. COMT genotype, gambling activity, and cognition. J Psychiatr Res. 2015 Sep; 68:371-6.
    View in: PubMed
    Score: 0.404
  47. Reduced cortical thickness in gambling disorder: a morphometric MRI study. Eur Arch Psychiatry Clin Neurosci. 2015 Dec; 265(8):655-61.
    View in: PubMed
    Score: 0.401
  48. Gambling disorder and its relationship with substance use disorders: implications for nosological revisions and treatment. Am J Addict. 2015 Mar; 24(2):126-131.
    View in: PubMed
    Score: 0.399
  49. Traumatic event exposure and gambling: associations with clinical, neurocognitive, and personality variables. Ann Clin Psychiatry. 2015 Feb; 27(1):16-24.
    View in: PubMed
    Score: 0.397
  50. Suicidality in non-treatment seeking young adults with subsyndromal gambling disorder. Psychiatr Q. 2014 Dec; 85(4):513-22.
    View in: PubMed
    Score: 0.392
  51. A preliminary comparison of cannabis use in subsyndromal gamblers: select neurocognitive and behavioral differences based on use. J Addict Med. 2014 Nov-Dec; 8(6):443-9.
    View in: PubMed
    Score: 0.390
  52. Obesity and gambling: neurocognitive and clinical associations. Acta Psychiatr Scand. 2015 May; 131(5):379-86.
    View in: PubMed
    Score: 0.389
  53. Impact of ADHD symptoms on clinical and cognitive aspects of problem gambling. Compr Psychiatry. 2015 Feb; 57:51-7.
    View in: PubMed
    Score: 0.389
  54. A single-blind study of 'as-needed' ecopipam for gambling disorder. Ann Clin Psychiatry. 2014 Aug; 26(3):179-86.
    View in: PubMed
    Score: 0.383
  55. One-year follow-up of subsyndromal gambling disorder in non-treatment-seeking young adults. Ann Clin Psychiatry. 2014 Aug; 26(3):199-205.
    View in: PubMed
    Score: 0.383
  56. Pharmacological treatments in pathological gambling. Br J Clin Pharmacol. 2014 Feb; 77(2):375-81.
    View in: PubMed
    Score: 0.370
  57. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014 Jan; 75(1):39-45.
    View in: PubMed
    Score: 0.368
  58. Prediction of alcohol and gambling problems in young adults by using a measure of decision making. J Addict Med. 2013 Sep-Oct; 7(5):314-9.
    View in: PubMed
    Score: 0.360
  59. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol. 2013 Nov; 23(11):1587-96.
    View in: PubMed
    Score: 0.358
  60. Phenomenology and treatment of behavioural addictions. Can J Psychiatry. 2013 May; 58(5):252-9.
    View in: PubMed
    Score: 0.351
  61. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013 Jun; 27(2):380-92.
    View in: PubMed
    Score: 0.350
  62. Personality dimensions and disorders in pathological gambling. Curr Opin Psychiatry. 2013 Jan; 26(1):107-12.
    View in: PubMed
    Score: 0.343
  63. Telescoping phenomenon in pathological gambling: association with gender and comorbidities. J Nerv Ment Dis. 2012 Nov; 200(11):996-8.
    View in: PubMed
    Score: 0.339
  64. The relationship of tobacco use with gambling problem severity and gambling treatment outcome. Psychol Addict Behav. 2013 Sep; 27(3):696-704.
    View in: PubMed
    Score: 0.336
  65. Gender-related clinical and neurocognitive differences in individuals seeking treatment for pathological gambling. J Psychiatr Res. 2012 Sep; 46(9):1206-11.
    View in: PubMed
    Score: 0.331
  66. Personality disorders and dimensions in pathological gambling. J Pers Disord. 2012 Jun; 26(3):381-92.
    View in: PubMed
    Score: 0.330
  67. Neurocognitive dysfunction in strategic and non-strategic gamblers. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 07; 38(2):336-40.
    View in: PubMed
    Score: 0.329
  68. Gambling disorders. Lancet. 2011 Nov 26; 378(9806):1874-84.
    View in: PubMed
    Score: 0.307
  69. Strategic vs nonstrategic gambling: characteristics of pathological gamblers based on gambling preference. Ann Clin Psychiatry. 2011 May; 23(2):105-12.
    View in: PubMed
    Score: 0.306
  70. A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity. Psychol Med. 2011 Oct; 41(10):2111-9.
    View in: PubMed
    Score: 0.304
  71. Cigarette smoking status in pathological gamblers: association with impulsivity and cognitive flexibility. Drug Alcohol Depend. 2011 Aug 01; 117(1):74-7.
    View in: PubMed
    Score: 0.301
  72. A 6-month follow-up of imaginal desensitization plus motivational interviewing in the treatment of pathological gambling. Ann Clin Psychiatry. 2011 Feb; 23(1):3-10.
    View in: PubMed
    Score: 0.301
  73. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
    View in: PubMed
    Score: 0.294
  74. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010 Dec; 212(4):603-12.
    View in: PubMed
    Score: 0.291
  75. Pharmacological treatment of adolescent pathological gambling. Int J Adolesc Med Health. 2010 Jan-Mar; 22(1):129-38.
    View in: PubMed
    Score: 0.279
  76. Characteristics of pathological gamblers with a problem gambling parent. Am J Addict. 2009 Nov-Dec; 18(6):462-9.
    View in: PubMed
    Score: 0.276
  77. Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial. Br J Psychiatry. 2009 Sep; 195(3):266-7.
    View in: PubMed
    Score: 0.273
  78. Pathologic gambling and bankruptcy. Compr Psychiatry. 2010 Mar-Apr; 51(2):115-20.
    View in: PubMed
    Score: 0.270
  79. Comparison of temperament and character between early- and late-onset Korean male pathological gamblers. J Gambl Stud. 2009 Dec; 25(4):447-53.
    View in: PubMed
    Score: 0.263
  80. Relationship of nicotine dependence, subsyndromal and pathological gambling, and other psychiatric disorders: data from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2009 Mar; 70(3):334-43.
    View in: PubMed
    Score: 0.263
  81. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
    View in: PubMed
    Score: 0.251
  82. Late-onset pathological gambling: clinical correlates and gender differences. J Psychiatr Res. 2009 Jan; 43(4):380-7.
    View in: PubMed
    Score: 0.249
  83. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
    View in: PubMed
    Score: 0.248
  84. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007 Sep 15; 62(6):652-7.
    View in: PubMed
    Score: 0.231
  85. Commentary: illegal behavior and pathological gambling. J Am Acad Psychiatry Law. 2007; 35(3):302-5.
    View in: PubMed
    Score: 0.227
  86. Medication management of pathological gambling. Minn Med. 2006 Sep; 89(9):44-8.
    View in: PubMed
    Score: 0.221
  87. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol. 2006 Jul; 21(4):203-9.
    View in: PubMed
    Score: 0.219
  88. Sexual orientation of men with pathological gambling: prevalence and psychiatric comorbidity in a treatment-seeking sample. Compr Psychiatry. 2006 Nov-Dec; 47(6):515-8.
    View in: PubMed
    Score: 0.216
  89. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.213
  90. Update on pathological gambling. Curr Psychiatry Rep. 2006 Feb; 8(1):53-8.
    View in: PubMed
    Score: 0.213
  91. Tobacco use and pathological gambling. Ann Clin Psychiatry. 2005 Oct-Dec; 17(4):237-41.
    View in: PubMed
    Score: 0.208
  92. Betting on dopamine. CNS Spectr. 2005 Apr; 10(4):268-70.
    View in: PubMed
    Score: 0.201
  93. Quality of life in kleptomania and pathological gambling. Compr Psychiatry. 2005 Jan-Feb; 46(1):34-7.
    View in: PubMed
    Score: 0.197
  94. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res. 2004 Aug 30; 128(1):79-88.
    View in: PubMed
    Score: 0.193
  95. Sleep Problems and Gambling Disorder: Cross-Sectional Relationships in a Young Cohort. J Gambl Stud. 2024 Dec; 40(4):2141-2151.
    View in: PubMed
    Score: 0.191
  96. Retrospective review of treatment retention in pathological gambling. Compr Psychiatry. 2004 Mar-Apr; 45(2):83-7.
    View in: PubMed
    Score: 0.186
  97. Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.
    View in: PubMed
    Score: 0.186
  98. Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr Scand. 2003 Sep; 108(3):203-7.
    View in: PubMed
    Score: 0.180
  99. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol. 2003 Jul; 18(4):243-9.
    View in: PubMed
    Score: 0.178
  100. Dissociative symptoms in pathological gambling. Psychopathology. 2003 Jul-Aug; 36(4):200-3.
    View in: PubMed
    Score: 0.178
  101. Autism and gambling: A systematic review, focusing on neurocognition. Neurosci Biobehav Rev. 2023 04; 147:105071.
    View in: PubMed
    Score: 0.173
  102. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003; 19(1):85-109.
    View in: PubMed
    Score: 0.172
  103. COVID-19 and resultant restrictions on gambling behaviour. Neurosci Biobehav Rev. 2022 12; 143:104932.
    View in: PubMed
    Score: 0.170
  104. Effectiveness of pharmacotherapy for pathological gambling: a chart review. Ann Clin Psychiatry. 2002 Sep; 14(3):155-61.
    View in: PubMed
    Score: 0.168
  105. Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet. Compr Psychiatry. 2022 10; 118:152346.
    View in: PubMed
    Score: 0.167
  106. Gambling disorder in the UK: key research priorities and the urgent need for independent research funding. Lancet Psychiatry. 2022 04; 9(4):321-329.
    View in: PubMed
    Score: 0.162
  107. Gender differences in pathological gamblers seeking medication treatment. Compr Psychiatry. 2002 Jan-Feb; 43(1):56-62.
    View in: PubMed
    Score: 0.160
  108. Parental bonding in pathological gambling disorder. Psychiatr Q. 2002; 73(3):239-47.
    View in: PubMed
    Score: 0.160
  109. Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry. 2001 Dec; 62(12):957-62.
    View in: PubMed
    Score: 0.159
  110. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Res. 2001 Nov 30; 104(3):205-12.
    View in: PubMed
    Score: 0.159
  111. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
    View in: PubMed
    Score: 0.157
  112. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001 Jul; 6(3):184-94.
    View in: PubMed
    Score: 0.155
  113. Characteristics of geriatric patients seeking medication treatment for pathologic gambling disorder. J Geriatr Psychiatry Neurol. 2001; 14(3):125-9.
    View in: PubMed
    Score: 0.149
  114. Firearm ownership among young adults: Associations with impulsivity and impulse control disorders. Ann Clin Psychiatry. 2020 08; 32(3):176-181.
    View in: PubMed
    Score: 0.145
  115. Gambling disorder. Nat Rev Dis Primers. 2019 07 25; 5(1):51.
    View in: PubMed
    Score: 0.135
  116. Impulsivity in Gambling Disorder and problem gambling: a meta-analysis. Neuropsychopharmacology. 2019 07; 44(8):1354-1361.
    View in: PubMed
    Score: 0.133
  117. Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions. Neuropsychol Rev. 2019 03; 29(1):93-102.
    View in: PubMed
    Score: 0.132
  118. Sleepiness and impulsivity: Findings in non-treatment seeking young adults. J Behav Addict. 2018 Sep 01; 7(3):737-742.
    View in: PubMed
    Score: 0.127
  119. Minnesota Impulse Disorders Interview (MIDI): Validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample. Psychiatry Res. 2018 07; 265:279-283.
    View in: PubMed
    Score: 0.124
  120. Neurocognitive Deficits Associated with Antisocial Personality Disorder in Non-treatment-seeking Young Adults. J Am Acad Psychiatry Law. 2016 Jun; 44(2):218-25.
    View in: PubMed
    Score: 0.109
  121. A cross-cultural study of gambling disorder: a comparison between women from Brazil and the United States. Braz J Psychiatry. 2016 Mar; 38(1):53-7.
    View in: PubMed
    Score: 0.107
  122. Electronic gaming machines and gambling disorder: A cross-cultural comparison between treatment-seeking subjects from Brazil and the United States. Psychiatry Res. 2015 Dec 15; 230(2):430-5.
    View in: PubMed
    Score: 0.104
  123. The importance of cross-cultural research in addictions. Aust N Z J Psychiatry. 2015 Sep; 49(9):851.
    View in: PubMed
    Score: 0.101
  124. Obesity and dissociable forms of impulsivity in young adults. CNS Spectr. 2015 Oct; 20(5):500-7.
    View in: PubMed
    Score: 0.100
  125. Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence? Addict Behav. 2014 Nov; 39(11):1632-1639.
    View in: PubMed
    Score: 0.094
  126. The effectiveness of a cognitive-behavioral intervention for pathological gambling: a country-wide study. Ann Clin Psychiatry. 2013 Nov; 25(4):250-6.
    View in: PubMed
    Score: 0.091
  127. Brain circuitry of compulsivity and impulsivity. CNS Spectr. 2014 Feb; 19(1):21-7.
    View in: PubMed
    Score: 0.088
  128. Neurocognitive deficits associated with shoplifting in young adults. Compr Psychiatry. 2012 Nov; 53(8):1049-55.
    View in: PubMed
    Score: 0.083
  129. Cognitive task performance and frequency of alcohol usage in young adults. J Addict Med. 2012 Jun; 6(2):106-11.
    View in: PubMed
    Score: 0.082
  130. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009 May 15; 167(1-2):161-8.
    View in: PubMed
    Score: 0.066
  131. Risk factors for problematic gambling: a critical literature review. J Gambl Stud. 2009 Mar; 25(1):67-92.
    View in: PubMed
    Score: 0.066
  132. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009 Mar 31; 166(1):76-84.
    View in: PubMed
    Score: 0.066
  133. The neurobiology of substance and behavioral addictions. CNS Spectr. 2006 Dec; 11(12):924-30.
    View in: PubMed
    Score: 0.056
  134. Compulsive aspects of impulse-control disorders. Psychiatr Clin North Am. 2006 Jun; 29(2):539-51, x.
    View in: PubMed
    Score: 0.054
  135. Pathological gambling and mood disorders: clinical associations and treatment implications. J Affect Disord. 2006 May; 92(1):109-16.
    View in: PubMed
    Score: 0.053
  136. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005; 21(4):431-43.
    View in: PubMed
    Score: 0.049
  137. Emotion regulation across psychiatric disorders. CNS Spectr. 2024 Jun; 29(3):215-220.
    View in: PubMed
    Score: 0.047
  138. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004 Jan-Mar; 16(1):27-34.
    View in: PubMed
    Score: 0.046
  139. Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
    View in: PubMed
    Score: 0.041
  140. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002 Jun; 63(6):501-7.
    View in: PubMed
    Score: 0.041
  141. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001 Jun 01; 49(11):914-21.
    View in: PubMed
    Score: 0.038
  142. Compulsive sexual behavior in young adults. Ann Clin Psychiatry. 2013 Aug; 25(3):193-200.
    View in: PubMed
    Score: 0.022
  143. Prevalence and correlates of fire-setting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2010 Sep; 71(9):1218-25.
    View in: PubMed
    Score: 0.018
  144. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.